Home » Blogpage 10

Blog

09/02/2014

Employment Class Actions for Wage Violations On The Rise

In what is coming to be referred to as "wage theft," the New York Times is reporting on an escalating number of class action lawsuits brought on behalf of employees of major U.S. companies to recover wages lost as a result of state and federal employment law violations.  Employment laws and regulations in California and other states, as well as federal law, set forth specific guidelines that must be followed by employers with regard to employee wages and working conditions.  These... Read More
08/27/2014

Phoenix VA Hospital Under Fire After New OIG Report

VA Hospital Delays Documented in OIG Report

Audet & Partners, LLP reports that a new report issued by the U.S. Department of Veteran Affairs (VA) Office of the Inspector General (OIG) has shed new light on the degree of substandard care rendered to U.S. veterans within the Phoenix VA hospital system. The extensive OIG Report (click here to access the complete Report) scrutinized medical records and additional information related to the care of 3,409 veterans awaiting treatment from the Phoenix VA system between April 2013 and April 2014.  Based... Read More
08/25/2014

Class Action Against Whole Foods Challenges Homeopathic Claims

Class Action Homeopathic Whole Foods

Audet & Partners, LLP reports that a new class action lawsuit recently brought in the U.S. District Court for the Southern District of Florida challenges claims made by Whole Foods Market, Inc. regarding products including Cough Ease for Kids, Cough Ease, Flu Ease and Arnica Montana 30C.  Each of these claims are based on the assertion that the company extracted a premium for these products from potentially hundreds of thousands of consumers by claiming that the products effectively treat the... Read More
08/14/2014

Pay-for-Delay Lawsuit Alleges Scheme Against Generic Opana Painkiller

Pay-for-Delay Lawsuit re Opana

Audet & Partners, LLP reports that a lawsuit has been brought in an Illinois federal court on behalf of an employee trust fund alleging an illegal scheme to deprive the market of generic Opana ER, an extended-release painkiller.  The Pennsylnavia Employees Benefit Trust Fund has accused Endo Pharmaceuticals Inc., and its subsidiary Penwest Pharmaceuticals Co., of orchestrating and implementing a strategy through which Endo essentially paid Impax Laboratories to delay for more than two years its introduction of generic Opana into... Read More
08/12/2014

Luvena Lawsuit by FDA Seeks to Curtail Sales

FDA Luvena Lawsuit

Audet & Partners, LLP reports that the U.S. Food and Drug Administration (FDA) has filed a lawsuit in the United States District Court for the Central District of California against Laclede, the manufacturer of Luvena vaginal moisturizer, to enjoin future sales of the Luvena product. In taking this extraordinary action, the FDA has alleged that Luvena falls within the FDA designation as a "New Drug."  Because Laclede failed to seek and obtain necessary FDA approval for a "new drug," the FDA... Read More